PathnSitu

Hyderabad, India Founded: 2013 • Age: 13 yrs
It functions as an offers products and services in ihc.
Annual revenue $2.9M Latest available
Total funding - Funding intelligence
Employees 101 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About PathnSitu

PathnSitu is a company based in Hyderabad (India) founded in 2013 by Kamal Prasad. The company has 101 employees as of March 31, 2023. PathnSitu operates in a competitive market with competitors including Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.

  • Headquarter Hyderabad, India
  • Employees 101 as on 31 Mar, 2023
  • Founders Kamal Prasad
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Pathnsitu Biotechnologies Private Limited
  • Date of Incorporation 06 Sep, 2013
  • Jurisdiction Uppal, Telangana, India
Operational Areas
Not available
Key Metrics
  • Annual Revenue
    $2.9 M (USD)
    36.87
    as on Mar 31, 2023
  • Net Profit
    $54.85 K (USD)
    -51.67
    as on Mar 31, 2023
  • EBITDA
    $430.19 K (USD)
    15.76
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    101

    as on Mar 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of PathnSitu

Premium access

Detailed funding history for PathnSitu

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by PathnSitu

Investments
Premium access

Investment portfolio details for PathnSitu

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - PathnSitu

Premium access

Detailed financials for PathnSitu

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Pathnsitu Comparisons

PathnSitu Primary company
Description
It functions as an offers products and services in ihc.
Location
Hyderabad, India
Founded Year
2013
Annual Revenue
$2.9 M (USD)
Net Profit
$54.85 K (USD)
EBITDA
$430.19 K (USD)
Employees
101
As of 2023
Premium access

Peer comparison for PathnSitu

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of PathnSitu

PathnSitu operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Reagents and kits are provided for clinical research applications.
Locked Locked Locked
Reagents and instruments are provided for life sciences research.
Locked Locked Locked
Antibodies and immunoassay kits are developed for research applications.
Locked Locked Locked
Developer of antibodies for the treatment of multiple diseases
Locked Locked Locked
Monoclonal antibody technology and products are developed by Epitomics.
Locked Locked Locked
Antibody and vaccine culture media products are developed.
Premium access

Detailed competitors of PathnSitu

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Pathnsitu

Premium access

Complete news archive for PathnSitu

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PathnSitu

PathnSitu was founded in 2013.

PathnSitu is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

As of Mar 31, 2023, the latest employee count at PathnSitu is 101.

Annual revenue of PathnSitu is $2.9M as on Mar 31, 2023.

PathnSitu it functions as an offers products and services in ihc, focusing on providing essential services. Active on platforms like Facebook, LinkedIn, it serves clients with dedicated solutions emphasizing quality and innovation. It continues to evolve, meeting industry challenges with strategic approaches and commitment to quality.

PathnSitu's top competitors include Sino Biological, GenScript and Y-Biologics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available